ENDOLOGIX INC /DE/·4

Aug 6, 5:15 PM ET

Thompson Matthew 4

4 · ENDOLOGIX INC /DE/ · Filed Aug 6, 2019

Insider Transaction Report

Form 4
Period: 2019-08-05
Thompson Matthew
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-08-05+30,43384,244 total
  • Award

    Option to Purchase

    2019-08-05$6.67/sh+60,867$405,98360,867 total
    Exercise: $6.67From: 2019-09-05Exp: 2029-08-05Common Stock (60,867 underlying)
Footnotes (2)
  • [F1]Performance restricted stock unit award based on predetermined goals.
  • [F2]Options vest ratably over thirty-six months.

Documents

1 file
  • 4
    wf-form4_156512611903617.xmlPrimary

    FORM 4